Given advanced immunodeficiency (CD4<200 cells/mm3) at ART initiation in all included women, it is not surprising that we observed somewhat lower pregnancy rates than the 9.0/100 women-years on ART recently reported from the MTCT-Plus initiative [12]. The gene discussed is CD4; the disease is immunodeficiency disease.